{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:51:00Z","timestamp":1772556660458,"version":"3.50.1"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,19]]},"DOI":"10.1093\/nar\/gkx111","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T08:56:49Z","timestamp":1487149009000},"page":"5153-5169","source":"Crossref","is-referenced-by-count":21,"title":["CTG repeat-targeting oligonucleotides for down-regulating Huntingtin expression"],"prefix":"10.1093","volume":"45","author":[{"given":"Eman M.","family":"Zaghloul","sequence":"first","affiliation":[]},{"given":"Olof","family":"Gissberg","sequence":"additional","affiliation":[]},{"given":"Pedro M.D.","family":"Moreno","sequence":"additional","affiliation":[]},{"given":"Lee","family":"Siggens","sequence":"additional","affiliation":[]},{"given":"Mattias","family":"H\u00e4llbrink","sequence":"additional","affiliation":[]},{"given":"Anna S.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[]},{"given":"Karl","family":"Ekwall","sequence":"additional","affiliation":[]},{"given":"Rula","family":"Zain","sequence":"additional","affiliation":[]},{"given":"Jesper","family":"Wengel","sequence":"additional","affiliation":[]},{"given":"Karin E.","family":"Lundin","sequence":"additional","affiliation":[]},{"given":"C.I. Edvard","family":"Smith","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"key\n\t\t\t\t20170518045139_B1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1076\/jcen.24.2.133.998","article-title":"Psychomotor, executive, and memory function in preclinical Huntington's disease","volume":"24","year":"2002","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"key\n\t\t\t\t20170518045139_B2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.brainresbull.2006.10.022","article-title":"Late stage care in Huntington's disease","volume":"72","year":"2007","journal-title":"Brain Res. Bull."},{"key":"key\n\t\t\t\t20170518045139_B3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170518045139_B4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","year":"2011","journal-title":"Lancet Neurol."},{"key":"key\n\t\t\t\t20170518045139_B5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis","volume":"27","year":"2012","journal-title":"Mov. Disord"},{"key":"key\n\t\t\t\t20170518045139_B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006549","article-title":"Huntington's disease: molecular basis of neurodegeneration","volume":"5","year":"2003","journal-title":"Expert Rev. Mol. Med."},{"key":"key\n\t\t\t\t20170518045139_B7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/nbdi.1996.0018","article-title":"Differential expression of normal and mutant Huntington's disease gene alleles","volume":"3","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20170518045139_B8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02257483","article-title":"Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat","volume":"20","year":"1994","journal-title":"Somat. Cell Mol. Genet."},{"key":"key\n\t\t\t\t20170518045139_B9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","year":"1995","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170518045139_B10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","year":"2009","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170518045139_B11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awr333","article-title":"Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum","volume":"135","year":"2012","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170518045139_B12","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1096\/fj.12-219220","article-title":"A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration","volume":"27","year":"2013","journal-title":"FASEB J."},{"key":"key\n\t\t\t\t20170518045139_B13","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the Rhesus Macaque as a potential therapy for Huntington's Disease","volume":"19","year":"2011","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170518045139_B14","doi-asserted-by":"crossref","first-page":"e1002481","DOI":"10.1371\/journal.pgen.1002481","article-title":"A pathogenic mechanism in Huntington's Disease involves small CAG-repeated RNAs with neurotoxic activity","volume":"8","year":"2012","journal-title":"Plos Genet."},{"key":"key\n\t\t\t\t20170518045139_B15","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1172\/JCI83185","article-title":"Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels","volume":"126","year":"2016","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170518045139_B16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cge.12385","article-title":"Personalized gene silencing therapeutics for Huntington disease","volume":"86","year":"2014","journal-title":"Clin. Genet."},{"key":"key\n\t\t\t\t20170518045139_B17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00109-013-1016-2","article-title":"RNA toxicity in polyglutamine disorders: concepts, models, and progress of research","volume":"91","year":"2013","journal-title":"J. Mol. Med."},{"key":"key\n\t\t\t\t20170518045139_B18","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/nar\/gkq1323","article-title":"Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference","volume":"39","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B19","doi-asserted-by":"crossref","first-page":"8938","DOI":"10.1093\/nar\/gkr608","article-title":"CAG repeats mimic CUG repeats in the misregulation of alternative splicing","volume":"39","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.molcel.2007.01.031","article-title":"Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets","volume":"25","year":"2007","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20170518045139_B21","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1515\/hsz-2012-0218","article-title":"Triplet repeats in transcripts: structural insights into RNA toxicity","volume":"393","year":"2012","journal-title":"Biol. Chem."},{"key":"key\n\t\t\t\t20170518045139_B22","first-page":"933","article-title":"Progress and challenges in RNA interference therapy for Huntington disease","volume":"66","year":"2009","journal-title":"Arch. Neurol."},{"key":"key\n\t\t\t\t20170518045139_B23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/nat.2013.0452","article-title":"Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification","volume":"24","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"key\n\t\t\t\t20170518045139_B24","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/mt.2014.153","article-title":"In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides","volume":"22","year":"2014","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170518045139_B25","doi-asserted-by":"crossref","first-page":"E3136","DOI":"10.1073\/pnas.1206506109","article-title":"Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6\/2 mice","volume":"109","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20170518045139_B26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","year":"2012","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170518045139_B27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1539","article-title":"Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs","volume":"27","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20170518045139_B28","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1093\/hmg\/ddu349","article-title":"Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity","volume":"23","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170518045139_B29","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1021\/bi101208k","article-title":"Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat","volume":"49","year":"2010","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170518045139_B30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/nat.2015.0547","article-title":"Allele-selective inhibition of mutant Huntingtin with 2-Thio- and C5- Triazolylphenyl-Deoxythymidine-modified antisense oligonucleotides","volume":"25","year":"2015","journal-title":"Nucleic Acid Ther."},{"key":"key\n\t\t\t\t20170518045139_B31","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cell.2012.08.002","article-title":"Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression","volume":"150","year":"2012","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170518045139_B32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/nat.2013.0476","article-title":"Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs","volume":"24","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"key\n\t\t\t\t20170518045139_B33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","article-title":"Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism","volume":"17","year":"2010","journal-title":"Chem. Biol."},{"key":"key\n\t\t\t\t20170518045139_B34","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1093\/nar\/gkr156","article-title":"Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats","volume":"39","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B35","doi-asserted-by":"crossref","first-page":"10426","DOI":"10.1093\/nar\/gkt825","article-title":"Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression","volume":"41","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajhg.2012.01.005","article-title":"Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region","volume":"90","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170518045139_B37","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/hum.2007.116","article-title":"Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts","volume":"19","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"key\n\t\t\t\t20170518045139_B38","doi-asserted-by":"crossref","first-page":"e107434","DOI":"10.1371\/journal.pone.0107434","article-title":"Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170518045139_B39","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene \/ allele-specific silencing of mutant huntingtin","volume":"19","year":"2011","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170518045139_B40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.drudis.2014.09.011","article-title":"Delivering a disease-modifying treatment for Huntington's disease","volume":"20","year":"2015","journal-title":"Drug Discov. Today"},{"key":"key\n\t\t\t\t20170518045139_B41","article-title":"Discovery and early clinical development of ISIS-HTTRx, the first HTT-lowering drug to be tested in patients with Huntington's Disease (PL01.002)","volume":"86","year":"2016","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170518045139_B42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice","volume":"12","year":"2005","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170518045139_B43","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1056\/NEJMcibr1209595","article-title":"Hunting down huntingtin","volume":"367","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170518045139_B44","first-page":"455","article-title":"LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition","year":"1998","journal-title":"Chem. Commun."},{"key":"key\n\t\t\t\t20170518045139_B45","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/nar\/gkq835","article-title":"Optimizing anti-gene oligonucleotide \u2018Zorro-LNA\u2019 for improved strand invasion into duplex DNA","volume":"39","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B46","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/nar\/gkp841","article-title":"Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents","volume":"38","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B47","doi-asserted-by":"crossref","first-page":"10718","DOI":"10.1021\/jo302036h","article-title":"Large scale synthesis of 2\u0384-amino-LNA thymine and 5-methylcytosine nucleosides","volume":"77","year":"2012","journal-title":"J. Org. Chem."},{"key":"key\n\t\t\t\t20170518045139_B48","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bbrc.2005.10.061","article-title":"siRNA-mediated inhibition of endogenous Huntington disease gene expression induces an aberrant configuration of the ER network in vitro","volume":"338","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"key\n\t\t\t\t20170518045139_B49","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1093\/nar\/gkq127","article-title":"Trinucleotide repeats in human genome and exome","volume":"38","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B50","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1074\/jbc.M409984200","article-title":"CAG repeats containing CAA interruptions form branched hairpin structures in spinocerebellar ataxia type 2 transcripts","volume":"280","year":"2005","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170518045139_B51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/nar\/18.1.157","article-title":"Site-specific inhibition of EcoRI restriction\/modification enzymes by a DNA triple helix","volume":"18","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B52","doi-asserted-by":"crossref","first-page":"8631","DOI":"10.1073\/pnas.89.18.8631","article-title":"Triple-helix formation by oligonucleotides containing the three bases thymine, cytosine, and guanine","volume":"89","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20170518045139_B53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170518045139_B54","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1101\/gad.824700","article-title":"Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription","volume":"14","year":"2000","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170518045139_B55","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1093\/nar\/gkr072","article-title":"PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation","volume":"39","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B56","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.biochi.2008.04.004","article-title":"Targeting DNA with triplex-forming oligonucleotides to modify gene sequence","volume":"90","year":"2008","journal-title":"Biochimie"},{"key":"key\n\t\t\t\t20170518045139_B57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/hum.2015.070","article-title":"Oligonucleotide therapies: the past and the present","volume":"26","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"key\n\t\t\t\t20170518045139_B58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-407676-1.00002-0","article-title":"Biological activity and biotechnological aspects of locked nucleic acids","volume":"82","year":"2013","journal-title":"Adv. Genet."},{"key":"key\n\t\t\t\t20170518045139_B59","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/nar\/gkt007","article-title":"Development of bis-locked nucleic acid (bisLNA) oligonucleotides for efficient invasion of supercoiled duplex DNA","volume":"41","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B60","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1096\/fj.06-7225com","article-title":"Zorro locked nucleic acid induces sequence-specific gene silencing","volume":"21","year":"2007","journal-title":"FASEB J."},{"key":"key\n\t\t\t\t20170518045139_B61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jgm.1124","article-title":"Sequence-specific inhibition of RNA polymerase III-dependent transcription using Zorro locked nucleic acid (LNA)","volume":"10","year":"2008","journal-title":"J. Gene Med."},{"key":"key\n\t\t\t\t20170518045139_B62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbagrm.2010.11.004","article-title":"Long-range DNA interactions are specifically altered by locked nucleic acid-targeting of a CTCF binding site","volume":"1809","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170518045139_B63","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1021\/bi700227g","article-title":"Inhibiting gene expression with locked nucleic acids (LNAs) that target chromosomal DNA","volume":"46","year":"2007","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170518045139_B64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0014-5793(95)00517-D","article-title":"Phosphorothioate oligonucleotides bind in a non sequence-specific manner to the nucleolar protein C23\/nucleolin","volume":"366","year":"1995","journal-title":"FEBS Lett."},{"key":"key\n\t\t\t\t20170518045139_B65","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1093\/nar\/gku484","article-title":"TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells","volume":"42","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B66","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1093\/nar\/gkv143","article-title":"Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages","volume":"43","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B67","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/nar\/30.9.1911","article-title":"Design of antisense oligonucleotides stabilized by locked nucleic acids","volume":"30","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170518045139_B68","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature05977","article-title":"Expandable DNA repeats and human disease","volume":"447","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170518045139_B69","doi-asserted-by":"crossref","first-page":"e17119","DOI":"10.1371\/journal.pone.0017119","article-title":"Unusual structures are present in DNA fragments containing super-long Huntingtin CAG repeats","volume":"6","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170518045139_B70","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1093\/hmg\/ddr263","article-title":"A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression","volume":"20","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170518045139_B71","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1101\/gad.1477006","article-title":"Phosphorylation and functions of the RNA polymerase II CTD","volume":"20","year":"2006","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170518045139_B72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2012.06.006","article-title":"Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions","volume":"162","year":"2012","journal-title":"J. Control Release"},{"key":"key\n\t\t\t\t20170518045139_B73","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-61779-424-7_25","article-title":"Silencing of gene expression by gymnotic delivery of antisense oligonucleotides","volume":"815","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"key\n\t\t\t\t20170518045139_B74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/adna.17731","article-title":"Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)\/2\u0384-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents","volume":"2","year":"2011","journal-title":"Artif DNA PNA XNA"},{"key":"key\n\t\t\t\t20170518045139_B75","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1172\/JCI76175","article-title":"Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model","volume":"124","year":"2014","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170518045139_B76","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/mtna.2014.1","article-title":"The dynamics of compound, transcript, and protein effects after treatment with 2OMePS antisense oligonucleotides in mdx mice","volume":"3","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"key\n\t\t\t\t20170518045139_B77","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1081\/NCN-100002312","article-title":"LNA (locked nucleic acid) and the diastereoisomeric alpha-L-LNA: conformational tuning and high-affinity recognition of DNA\/RNA targets","volume":"20","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"key\n\t\t\t\t20170518045139_B78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1039\/C0OB00532K","article-title":"Amino acids attached to 2\u0384-amino-LNA: synthesis and excellent duplex stability","volume":"9","year":"2011","journal-title":"Org. Biomol. Chem."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/45\/9\/5153\/17183431\/gkx111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T12:13:32Z","timestamp":1601640812000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article-lookup\/doi\/10.1093\/nar\/gkx111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":78,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,2,17]]},"published-print":{"date-parts":[[2017,5,19]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkx111","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]}}}